Enforcement record

Administrative Guidance disclosure naming ＰＭＤＡ

ＰＭＤＡ (Pharmaceutical Affairs Act)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Pharmaceutical Affairs ActMinistry of Health, Labour and WelfareGovernment disclosure26 October 2015

Action type

Administrative Guidance

Law

Pharmaceutical Affairs Act

Authority

Ministry of Health, Labour and Welfare

Action date

26 October 2015

RegBase evidence report

Japanese public-record enforcement check

Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.

Report ID: RB-EN-ENFORCEMENT-OTHER-PMDA-201510-202607272323
Generated at: 28 July 2026 at 08:23
Record URL: https://regbase.jp/en/enforcement/other-pmda-20151026

1. Review Summary

Disclosure name	ＰＭＤＡ	Corporate Number	Not stated in the disclosure
Enforcement record	1 record	Other confirmed records for this company	Outside this report's scope
Action date	26 October 2015	Authority	Ministry of Health, Labour and Welfare
Law	Pharmaceutical Affairs Act	Action type	Administrative Guidance
Source status	Preserved public-source archive recorded

This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.

2. Published Information

Published name	ＰＭＤＡ

3. Enforcement Record

Target name in disclosure	ＰＭＤＡ
Authority	Ministry of Health, Labour and Welfare (厚生労働省)
Law / action type	Pharmaceutical Affairs Act / Administrative Guidance
Action / announcement date	Action: 26 October 2015 / Announcement: 5 April 2026
English summary	The Ministry of Health, Labour and Welfare / PMDA secures veto rights on major decisions at the general meeting and management committee, and is a permanent member of the management committee.
Original Japanese text	厚生労働省/ＰＭＤＡは総会及び管理委員会において主要な決定事項に関する拒否権を確保するとともに、管理委員会の常任メンバーとなっています。
Official source	https://www.mhlw.go.jp/stf/houdou/0000102412.html
Source archive	https://kiroku.today/a/edac268b1ahfox2g
Extraction / evidence timestamps	Extracted: 25 April 2026 at 09:07 / Evidence checked: 25 April 2026 at 09:07 / Archive captured: 12 July 2026 at 15:51

4. Business Location and Permit Details

No additional structured business-location or permit fields are recorded for this disclosure.

5. Other Confirmed Records for This Company

This report covers the single government disclosure shown on this page.

Reviewer Notes

Reviewer		Team / company
Review purpose
Additional notes

□ Official source URL or archived source was checked.
□ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
□ This document is understood as a public-record evidence file, not a credit decision or legal opinion.

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming ＰＭＤＡ

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for ＰＭＤＡ

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack

For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%EF%BC%B0%EF%BC%AD%EF%BC%A4%EF%BC%A1&limit=10

Open JSON Specs

Action summary

Company: ＰＭＤＡJapanese only
Original: ＰＭＤＡ
Governing law: Pharmaceutical Affairs Act
薬事法
Action type: Administrative Guidance
行政指導
Action date: 26 October 2015
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

The Ministry of Health, Labour and Welfare / PMDA secures veto rights on major decisions at the general meeting and management committee, and is a permanent member of the management committee.

Show original Japanese text

厚生労働省/ＰＭＤＡは総会及び管理委員会において主要な決定事項に関する拒否権を確保するとともに、管理委員会の常任メンバーとなっています。

Compliance context

Low-medium

Administrative guidance or supervision was publicly disclosed by the authority.

Japanese regulatory disclosure under Pharmaceutical Affairs Act.

Use as a monitoring signal. Confirm details before treating it as a formal sanction.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-25T00:07:34.177+00:00
Evidence checked: 2026-04-25T00:07:34.177+00:00
Archive captured: 2026-07-12T06:51:08.290702+00:00

Show audit JSON

{
  "record": {
    "id": "fe85667d-8204-49bc-a6eb-fce7916a7451",
    "url": "https://regbase.jp/en/enforcement/other-pmda-20151026",
    "company_name_original": "ＰＭＤＡ",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "薬事法",
      "en": "Pharmaceutical Affairs Act"
    },
    "action_type": {
      "ja": "行政指導",
      "en": "Administrative Guidance"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 60,
    "method": "extracted_japanese_name",
    "method_label": "Company name extracted from the Japanese public disclosure",
    "notes": "The linked company profile has not been verified under the current identity policy."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Low-medium",
    "actionMeaning": "Administrative guidance or supervision was publicly disclosed by the authority.",
    "practicalNote": "Use as a monitoring signal. Confirm details before treating it as a formal sanction.",
    "lawContext": "Japanese regulatory disclosure under Pharmaceutical Affairs Act."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-pmda-20151026",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000102412.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/edac268b1ahfox2g",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000102412.html",
    "archiveCapturedAt": "2026-07-12T06:51:08.290702+00:00",
    "extractedAt": "2026-04-25T00:07:34.177+00:00",
    "translatedAt": "2026-05-01T06:57:38.376+00:00",
    "evidenceCheckedAt": "2026-04-25T00:07:34.177+00:00",
    "generatedAt": "2026-07-27T23:23:33.987Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.